|
|
||||||||
Original Research Communications |
1 From the Division of Nutrition and Physical Activity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta.
| ABSTRACT |
|---|
|
|
|---|
Objective: Using a population-based sample and adjusting for important covariates, we asked whether serum vitamin C concentrations in persons with newly diagnosed diabetes differed from those in persons without diabetes.
Design: Data were obtained from the third National Health and Nutrition Examination Survey (19881994). Serum vitamin C was assayed by using reversed-phase HPLC with multiwavelength detection. Diabetes status (n = 237 persons with diabetes; n = 1803 persons without diabetes) was determined by oral-glucose-tolerance testing of the sample aged 4074 y.
Results: After adjustment for age and sex, mean serum vitamin C concentrations were significantly lower in persons with newly diagnosed diabetes than in those without diabetes. After adjustment for dietary intake of vitamin C and other important covariates, however, mean concentrations did not differ according to diabetes status.
Conclusion: When assessing serum vitamin C concentrations by diabetes status in the future, researchers should measure and account for all factors that influence serum vitamin C concentrations.
Key Words: Ascorbic acid blood chemical analysis diabetes mellitus diet surveys epidemiology population NHANES III vitamin C oral-glucose-tolerance test third National Health and Nutrition Examination Survey
| INTRODUCTION |
|---|
|
|
|---|
To better assess whether persons with diabetes have low serum vitamin C concentrations, we used a population-based survey of US citizens to compare those newly diagnosed with diabetes with those without diabetes. We accounted for many important cofactors, including dietary intake of vitamin C, physical activity, and number of cigarettes smoked during the 5 d preceding examination.
| METHODS |
|---|
|
|
|---|
Serum vitamin C was assayed at the NHANES laboratory at the Centers for Disease Control and Prevention by using reversed-phase HPLC with multiwavelength detection. Detailed laboratory procedures for this assay were published elsewhere (6). To improve the normality of the serum vitamin C distribution, we log-transformed the serum vitamin C concentrations.
Participants aged 4074 y who were not pregnant, not taking insulin, and who did not have certain medical conditions were eligible for an oral-glucose-tolerance test (OGTT). Those who agreed to undergo an OGTT were randomly assigned to a morning, afternoon, or evening session, but only those assigned to the morning session were asked to fast for
10 h, which is the recommendation of the World Health Organization (WHO; 7). Because we used the WHO criteria to classify persons by diabetes status, we restricted our analyses to those participants attending the morning session (n = 3882). We excluded all persons who said they had previously diagnosed diabetes or who indicated that they did not know whether they had diabetes (n = 462). Of the 3420 persons remaining, we excluded the 259 persons who did not fast for
10 h and the 265 persons who did not have their blood drawn at 2 h ±
16 min. Of the 2896 persons still remaining, we excluded those who received an examination in their home (n = 86) because we wanted to focus on healthy, ambulatory persons. We also eliminated participants who did not answer the complete set of questions used in our analyses (n = 288). Finally, we excluded persons who had impaired glucose tolerance (IGT)a fasting plasma glucose concentration (FPG) of <7.8 mmol/L (140 mg/dL) with a 2-h value of 7.811.0 mmol/L (140199 mg/dL) (n = 482). Thus, our final sample consisted of 2040 men and women. Persons with an FPG of
7.8 mmol/L or <7.8 mmol/L with a 2-h value of
11.1 mmol/L (200 mg/dL) were considered to have newly diagnosed diabetes (n = 237). Persons with an FPG of <7.8 mmol/L with a 2-h value <7.8 mmol/L were considered to have normal glucose tolerance (n = 1803).
We examined serum vitamin C concentrations by diabetes status while controlling for sociodemographic, behavioral, anthropometric, and dietary variables, which included age (y), sex, race (white or other), education (y), body mass index (in kg/m2), number of cigarettes smoked during the past 5 d, alcohol consumed in the previous 24 h (g), length of fast before clinic attendance (h), and physical activity (vigorously active, moderately active, lightly active, or sedentary).
Being vigorously active was defined as participating
3 times/wk in an activity with a metabolic equivalent (MET) level of
6 for participants who were aged
60 y and 7 for participants who were <60 y. The term "moderately active" was defined as participating
5 times/wk in physical activities,
2 of which were defined as vigorous. "Lightly active" was defined as participation that was not "vigorously active" or "moderately active." "Sedentary" was defined as engaging in no leisure-time physical activity.
We also adjusted for total vitamin C consumed in the previous 24 h, which was estimated by summing the amount from food and from supplements assumed to have been taken in the previous 24 h. For supplements, we relied on a series of questions about the vitamins or minerals the participant had taken in the previous month. We used the answers to these to estimate the average daily amount of supplemental vitamin C (the participant was not asked about specific supplements during the 24-h recall). For example, if total supplemental vitamin C for 1 mo was estimated at 4800 mg, we calculated the average daily intake as 160 mg. We added this amount to the amount of vitamin C from food only if the respondent responded positively to the question, "Have you taken any vitamins or minerals during the past 24 h?" For food, we relied on a single 24-h recall that was administered at the clinic examination; results were coded by using the US Department of Agriculture survey nutrient database (8).
Because of the complex survey design of NHANES III, we used SUDAAN (9) to conduct a weighted regression analysis of diabetes status on the logarithm of serum vitamin C concentrations while adjusting for the variables listed previously. This regression analysis produced a test of the difference of mean serum vitamin C concentration between those persons with newly diagnosed diabetes and those without diabetes. Adjusted mean vitamin C concentrations were produced by using SAS (10).
To test some biological mechanisms that may influence serum vitamin C concentrations, we independently examined the relations of 4 variables with serum vitamin C concentrations after adjusting for all of the factors described above. These 4 variables were urinary frequency (an indicator of failure to reabsorb vitamin C) and concentrations of fasting plasma glucose, fasting insulin, and C-reactive protein (a measure of inflammation).
| RESULTS |
|---|
|
|
|---|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Of 23 studies reviewed previously (1), only 7 found that blood vitamin C concentrations in persons with diabetes were not significantly lower than concentrations in persons without diabetes (4, 1116). In 2 of those 7 studies, persons with diabetes actually had higher blood concentrations than the comparison group (4, 11). In 1 of those 2 studies, it seems likely that results were influenced by the provision of extensive dietary instruction to persons with diabetes that promoted the benefits of consuming fruit and vegetables (11). In the other, persons with diabetes were compared with critically ill persons without diabetes (4). Paralleling our finding for a measure of inflammation (concentration of C-reactive protein), researchers in that study found that illness was associated with lower plasma vitamin C concentrations. In the remaining studies that did not find vitamin C concentrations to be lower in persons with diabetes, comparability of the 2 groups was uncertain because dietary intake and illness status were generally not reported. We note that none of the studies examined urinary frequency, a factor we found to be inversely associated with serum vitamin C concentrations.
Our study was an improvement over previous studies in that it compared relatively healthy persons with newly diagnosed diabetes with their nondiabetic counterparts and adjusted for several important covariates. As in all cross-sectional studies, however, serum vitamin concentrations and diabetes are both assessed at the same point in time. Thus, if a positive association had been detected, it would have been difficult to determine whether serum vitamin C concentrations predicted diabetes status or vice versa. Furthermore, our assessment of vitamin C intake was probably not entirely satisfactory. First, to assess intake of supplements we used an indirect method that assumed that use over 1 mo could be applied to a single 24-h period in which the exact type of supplement was not known. For persons who do not take the same supplements every day, this approach seems particularly suspect. Second, the 24-h recall method for estimating dietary vitamin C intakes could have produced some data that misrepresented actual experience. For example, people may overreport consumption of those foods they eat most frequently (17), and those who are sensitive to criticism or praise may overreport those foods they believe are healthiest (18). Inaccuracies in reporting could distort comparisons of mean concentrations between persons with and without diabetes, but more information would be needed before conclusions on any effects of misreporting could be drawn.
On the other hand, the NHANES III 24-h dietary recall was administered by using standardized, computerized probes; edited carefully for completeness; and verified to determine the accuracy of extreme values (5). Indeed, 95% of participants completed the 24-h dietary recall, which suggests that errors introduced in our study because of poor survey methods should have been quite small.
In summary, after we adjusted for several important covariates, we found that serum vitamin C concentrations did not differ significantly by diabetes status. Future investigations on this topic should adjust serum concentrations for dietary intake of the vitamin and other factors that are related to both serum concentrations and diabetes status. In particular, researchers may want to examine the extent to which frequent urination or degree of inflammation lowers serum vitamin C concentrations. By conducting more rigorous scientific studies, it may be possible to achieve consensus on whether diabetes causes low serum vitamin C concentrations. Until that time, persons with diabetes (and all others) can likely attain adequate serum vitamin C concentrations by not smoking cigarettes and by following the Dietary Guidelines for Americans (19), which suggests that most energy be obtained from grains, fruit, and vegetables.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A.-H. Harding, N. J. Wareham, S. A. Bingham, K. Khaw, R. Luben, A. Welch, and N. G. Forouhi Plasma Vitamin C Level, Fruit and Vegetable Consumption, and the Risk of New-Onset Type 2 Diabetes Mellitus: The European Prospective Investigation of Cancer-Norfolk Prospective Study Arch Intern Med, July 28, 2008; 168(14): 1493 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Czernichow, A. Couthouis, S. Bertrais, A.-C. Vergnaud, L. Dauchet, P. Galan, and S. Hercberg Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 395 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asao, W.H. L. Kao, K. Baptiste-Roberts, K. Bandeen-Roche, T. P. Erlinger, and F. L. Brancati Short Stature and the Risk of Adiposity, Insulin Resistance, and Type 2 Diabetes in Middle Age: The Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 Diabetes Care, July 1, 2006; 29(7): 1632 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Lee, D. Y. Liu, D. R. Jacobs Jr., H.-R. Shin, K. Song, I.-K. Lee, B. Kim, and R. C. Hider Common Presence of Non-Transferrin-Bound Iron Among Patients With Type 2 Diabetes Diabetes Care, May 1, 2006; 29(5): 1090 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Lee, A. R Folsom, L. Harnack, B. Halliwell, and D. R Jacobs Jr Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1194 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S Hampl, C. A. Taylor, and C. S. Johnston Vitamin C Deficiency and Depletion in the United States: The Third National Health and Nutrition Examination Survey, 1988 to 1994 Am J Public Health, May 1, 2004; 94(5): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Montonen, P. Knekt, R. Jarvinen, and A. Reunanen Dietary Antioxidant Intake and Risk of Type 2 Diabetes Diabetes Care, February 1, 2004; 27(2): 362 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuroki, K. Isshiki, and G. L. King Oxidative Stress: The Lead or Supporting Actor in the Pathogenesis of Diabetic Complications J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S216 - 220. [Full Text] [PDF] |
||||
![]() |
K. Ylonen, G. Alfthan, L. Groop, C. Saloranta, A. Aro, S. M Virtanen, and the Botnia Research Group Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1434 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Mooradian Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines Arch Intern Med, January 13, 2003; 163(1): 33 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J Lenton, A. T Sane, H. Therriault, A. M Cantin, H. Payette, and J R. Wagner Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency Am. J. Clinical Nutrition, January 1, 2003; 77(1): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF] |
||||
![]() |
U. N. Das Exploring the actions of vitamin C. Can. Med. Assoc. J., July 10, 2001; 165(1): 13 - 14. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |